Targeted peptide measurements in biology and medicine

Best practices for mass spectrometry-based assay development using a fit-for-purpose approach

Steven A. Carr, Susan E. Abbatiello, Bradley L. Ackermann, Christoph Borchers, Bruno Domon, Eric W. Deutsch, Russell P. Grant, Andrew N. Hoofnagle, Ruth Hüttenhain, John M. Koomen, Daniel C. Liebler, Tao Liu, Brendan MacLean, D. R. Mani, Elizabeth Mansfield, Hendrik Neubert, Amanda G. Paulovich, Lukas Reiter, Olga Vitek, Ruedi Aebersold & 25 others Leigh Anderson, Robert Bethem, Josip Blonder, Emily Boja, Julianne Botelho, Michael Boyne, Ralph A. Bradshaw, Alma L. Burlingame, Daniel Chan, Hasmik Keshishian, Eric Kuhn, Christopher Kinsinger, Jerry S H Lee, Sang-Won Lee, Robert Moritz, Juan Oses-Prieto, Nader Rifai, James Ritchie, Henry Rodriguez, Pothur R. Srinivas, R. Reid Townsend, Jennifer Van Eyk, Gordon Whiteley, Arun Wiita, Susan Weintraub

Research output: Contribution to journalArticle

271 Citations (Scopus)

Abstract

Adoption of targeted mass spectrometry (MS) approaches such as multiple reaction monitoring (MRM) to study biological and biomedical questions is well underway in the proteomics community. Successful application depends on the ability to generate reliable assays that uniquely and confidently identify target peptides in a sample. Unfortunately, there is a wide range of criteria being applied to say that an assay has been successfully developed. There is no consensus on what criteria are acceptable and little understanding of the impact of variable criteria on the quality of the results generated. Publications describing targeted MS assays for peptides frequently do not contain sufficient information for readers to establish confidence that the tests work as intended or to be able to apply the tests described in their own labs. Guidance must be developed so that targeted MS assays with established performance can be made widely distributed and applied by many labs worldwide. To begin to address the problems and their solutions, a workshop was held at the National Institutes of Health with representatives from the multiple communities developing and employing targeted MS assays. Participants discussed the analytical goals of their experiments and the experimental evidence needed to establish that the assays they develop work as intended and are achieving the required levels of performance. Using this "fit-for-purpose" approach, the group defined three tiers of assays distinguished by their performance and extent of analytical characterization. Computational and statistical tools useful for the analysis of targeted MS results were described. Participants also detailed the information that authors need to provide in their manuscripts to enable reviewers and readers to clearly understand what procedures were performed and to evaluate the reliability of the peptide or protein quantification measurements reported. This paper presents a summary of the meeting and recommendations.

Original languageEnglish
Pages (from-to)907-917
Number of pages11
JournalMolecular and Cellular Proteomics
Volume13
Issue number3
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Practice Guidelines
Medicine
Mass spectrometry
Assays
Mass Spectrometry
Peptides
Manuscripts
National Institutes of Health (U.S.)
Proteomics
Publications
Education
Health
Monitoring
Proteins
Experiments

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Analytical Chemistry

Cite this

Targeted peptide measurements in biology and medicine : Best practices for mass spectrometry-based assay development using a fit-for-purpose approach. / Carr, Steven A.; Abbatiello, Susan E.; Ackermann, Bradley L.; Borchers, Christoph; Domon, Bruno; Deutsch, Eric W.; Grant, Russell P.; Hoofnagle, Andrew N.; Hüttenhain, Ruth; Koomen, John M.; Liebler, Daniel C.; Liu, Tao; MacLean, Brendan; Mani, D. R.; Mansfield, Elizabeth; Neubert, Hendrik; Paulovich, Amanda G.; Reiter, Lukas; Vitek, Olga; Aebersold, Ruedi; Anderson, Leigh; Bethem, Robert; Blonder, Josip; Boja, Emily; Botelho, Julianne; Boyne, Michael; Bradshaw, Ralph A.; Burlingame, Alma L.; Chan, Daniel; Keshishian, Hasmik; Kuhn, Eric; Kinsinger, Christopher; Lee, Jerry S H; Lee, Sang-Won; Moritz, Robert; Oses-Prieto, Juan; Rifai, Nader; Ritchie, James; Rodriguez, Henry; Srinivas, Pothur R.; Townsend, R. Reid; Van Eyk, Jennifer; Whiteley, Gordon; Wiita, Arun; Weintraub, Susan.

In: Molecular and Cellular Proteomics, Vol. 13, No. 3, 01.01.2014, p. 907-917.

Research output: Contribution to journalArticle

Carr, SA, Abbatiello, SE, Ackermann, BL, Borchers, C, Domon, B, Deutsch, EW, Grant, RP, Hoofnagle, AN, Hüttenhain, R, Koomen, JM, Liebler, DC, Liu, T, MacLean, B, Mani, DR, Mansfield, E, Neubert, H, Paulovich, AG, Reiter, L, Vitek, O, Aebersold, R, Anderson, L, Bethem, R, Blonder, J, Boja, E, Botelho, J, Boyne, M, Bradshaw, RA, Burlingame, AL, Chan, D, Keshishian, H, Kuhn, E, Kinsinger, C, Lee, JSH, Lee, S-W, Moritz, R, Oses-Prieto, J, Rifai, N, Ritchie, J, Rodriguez, H, Srinivas, PR, Townsend, RR, Van Eyk, J, Whiteley, G, Wiita, A & Weintraub, S 2014, 'Targeted peptide measurements in biology and medicine: Best practices for mass spectrometry-based assay development using a fit-for-purpose approach', Molecular and Cellular Proteomics, vol. 13, no. 3, pp. 907-917. https://doi.org/10.1074/mcp.M113.036095
Carr, Steven A. ; Abbatiello, Susan E. ; Ackermann, Bradley L. ; Borchers, Christoph ; Domon, Bruno ; Deutsch, Eric W. ; Grant, Russell P. ; Hoofnagle, Andrew N. ; Hüttenhain, Ruth ; Koomen, John M. ; Liebler, Daniel C. ; Liu, Tao ; MacLean, Brendan ; Mani, D. R. ; Mansfield, Elizabeth ; Neubert, Hendrik ; Paulovich, Amanda G. ; Reiter, Lukas ; Vitek, Olga ; Aebersold, Ruedi ; Anderson, Leigh ; Bethem, Robert ; Blonder, Josip ; Boja, Emily ; Botelho, Julianne ; Boyne, Michael ; Bradshaw, Ralph A. ; Burlingame, Alma L. ; Chan, Daniel ; Keshishian, Hasmik ; Kuhn, Eric ; Kinsinger, Christopher ; Lee, Jerry S H ; Lee, Sang-Won ; Moritz, Robert ; Oses-Prieto, Juan ; Rifai, Nader ; Ritchie, James ; Rodriguez, Henry ; Srinivas, Pothur R. ; Townsend, R. Reid ; Van Eyk, Jennifer ; Whiteley, Gordon ; Wiita, Arun ; Weintraub, Susan. / Targeted peptide measurements in biology and medicine : Best practices for mass spectrometry-based assay development using a fit-for-purpose approach. In: Molecular and Cellular Proteomics. 2014 ; Vol. 13, No. 3. pp. 907-917.
@article{53820e5240fd4d6a8ff36466fd25c4ab,
title = "Targeted peptide measurements in biology and medicine: Best practices for mass spectrometry-based assay development using a fit-for-purpose approach",
abstract = "Adoption of targeted mass spectrometry (MS) approaches such as multiple reaction monitoring (MRM) to study biological and biomedical questions is well underway in the proteomics community. Successful application depends on the ability to generate reliable assays that uniquely and confidently identify target peptides in a sample. Unfortunately, there is a wide range of criteria being applied to say that an assay has been successfully developed. There is no consensus on what criteria are acceptable and little understanding of the impact of variable criteria on the quality of the results generated. Publications describing targeted MS assays for peptides frequently do not contain sufficient information for readers to establish confidence that the tests work as intended or to be able to apply the tests described in their own labs. Guidance must be developed so that targeted MS assays with established performance can be made widely distributed and applied by many labs worldwide. To begin to address the problems and their solutions, a workshop was held at the National Institutes of Health with representatives from the multiple communities developing and employing targeted MS assays. Participants discussed the analytical goals of their experiments and the experimental evidence needed to establish that the assays they develop work as intended and are achieving the required levels of performance. Using this {"}fit-for-purpose{"} approach, the group defined three tiers of assays distinguished by their performance and extent of analytical characterization. Computational and statistical tools useful for the analysis of targeted MS results were described. Participants also detailed the information that authors need to provide in their manuscripts to enable reviewers and readers to clearly understand what procedures were performed and to evaluate the reliability of the peptide or protein quantification measurements reported. This paper presents a summary of the meeting and recommendations.",
author = "Carr, {Steven A.} and Abbatiello, {Susan E.} and Ackermann, {Bradley L.} and Christoph Borchers and Bruno Domon and Deutsch, {Eric W.} and Grant, {Russell P.} and Hoofnagle, {Andrew N.} and Ruth H{\"u}ttenhain and Koomen, {John M.} and Liebler, {Daniel C.} and Tao Liu and Brendan MacLean and Mani, {D. R.} and Elizabeth Mansfield and Hendrik Neubert and Paulovich, {Amanda G.} and Lukas Reiter and Olga Vitek and Ruedi Aebersold and Leigh Anderson and Robert Bethem and Josip Blonder and Emily Boja and Julianne Botelho and Michael Boyne and Bradshaw, {Ralph A.} and Burlingame, {Alma L.} and Daniel Chan and Hasmik Keshishian and Eric Kuhn and Christopher Kinsinger and Lee, {Jerry S H} and Sang-Won Lee and Robert Moritz and Juan Oses-Prieto and Nader Rifai and James Ritchie and Henry Rodriguez and Srinivas, {Pothur R.} and Townsend, {R. Reid} and {Van Eyk}, Jennifer and Gordon Whiteley and Arun Wiita and Susan Weintraub",
year = "2014",
month = "1",
day = "1",
doi = "10.1074/mcp.M113.036095",
language = "English",
volume = "13",
pages = "907--917",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Targeted peptide measurements in biology and medicine

T2 - Best practices for mass spectrometry-based assay development using a fit-for-purpose approach

AU - Carr, Steven A.

AU - Abbatiello, Susan E.

AU - Ackermann, Bradley L.

AU - Borchers, Christoph

AU - Domon, Bruno

AU - Deutsch, Eric W.

AU - Grant, Russell P.

AU - Hoofnagle, Andrew N.

AU - Hüttenhain, Ruth

AU - Koomen, John M.

AU - Liebler, Daniel C.

AU - Liu, Tao

AU - MacLean, Brendan

AU - Mani, D. R.

AU - Mansfield, Elizabeth

AU - Neubert, Hendrik

AU - Paulovich, Amanda G.

AU - Reiter, Lukas

AU - Vitek, Olga

AU - Aebersold, Ruedi

AU - Anderson, Leigh

AU - Bethem, Robert

AU - Blonder, Josip

AU - Boja, Emily

AU - Botelho, Julianne

AU - Boyne, Michael

AU - Bradshaw, Ralph A.

AU - Burlingame, Alma L.

AU - Chan, Daniel

AU - Keshishian, Hasmik

AU - Kuhn, Eric

AU - Kinsinger, Christopher

AU - Lee, Jerry S H

AU - Lee, Sang-Won

AU - Moritz, Robert

AU - Oses-Prieto, Juan

AU - Rifai, Nader

AU - Ritchie, James

AU - Rodriguez, Henry

AU - Srinivas, Pothur R.

AU - Townsend, R. Reid

AU - Van Eyk, Jennifer

AU - Whiteley, Gordon

AU - Wiita, Arun

AU - Weintraub, Susan

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Adoption of targeted mass spectrometry (MS) approaches such as multiple reaction monitoring (MRM) to study biological and biomedical questions is well underway in the proteomics community. Successful application depends on the ability to generate reliable assays that uniquely and confidently identify target peptides in a sample. Unfortunately, there is a wide range of criteria being applied to say that an assay has been successfully developed. There is no consensus on what criteria are acceptable and little understanding of the impact of variable criteria on the quality of the results generated. Publications describing targeted MS assays for peptides frequently do not contain sufficient information for readers to establish confidence that the tests work as intended or to be able to apply the tests described in their own labs. Guidance must be developed so that targeted MS assays with established performance can be made widely distributed and applied by many labs worldwide. To begin to address the problems and their solutions, a workshop was held at the National Institutes of Health with representatives from the multiple communities developing and employing targeted MS assays. Participants discussed the analytical goals of their experiments and the experimental evidence needed to establish that the assays they develop work as intended and are achieving the required levels of performance. Using this "fit-for-purpose" approach, the group defined three tiers of assays distinguished by their performance and extent of analytical characterization. Computational and statistical tools useful for the analysis of targeted MS results were described. Participants also detailed the information that authors need to provide in their manuscripts to enable reviewers and readers to clearly understand what procedures were performed and to evaluate the reliability of the peptide or protein quantification measurements reported. This paper presents a summary of the meeting and recommendations.

AB - Adoption of targeted mass spectrometry (MS) approaches such as multiple reaction monitoring (MRM) to study biological and biomedical questions is well underway in the proteomics community. Successful application depends on the ability to generate reliable assays that uniquely and confidently identify target peptides in a sample. Unfortunately, there is a wide range of criteria being applied to say that an assay has been successfully developed. There is no consensus on what criteria are acceptable and little understanding of the impact of variable criteria on the quality of the results generated. Publications describing targeted MS assays for peptides frequently do not contain sufficient information for readers to establish confidence that the tests work as intended or to be able to apply the tests described in their own labs. Guidance must be developed so that targeted MS assays with established performance can be made widely distributed and applied by many labs worldwide. To begin to address the problems and their solutions, a workshop was held at the National Institutes of Health with representatives from the multiple communities developing and employing targeted MS assays. Participants discussed the analytical goals of their experiments and the experimental evidence needed to establish that the assays they develop work as intended and are achieving the required levels of performance. Using this "fit-for-purpose" approach, the group defined three tiers of assays distinguished by their performance and extent of analytical characterization. Computational and statistical tools useful for the analysis of targeted MS results were described. Participants also detailed the information that authors need to provide in their manuscripts to enable reviewers and readers to clearly understand what procedures were performed and to evaluate the reliability of the peptide or protein quantification measurements reported. This paper presents a summary of the meeting and recommendations.

UR - http://www.scopus.com/inward/record.url?scp=84895555123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895555123&partnerID=8YFLogxK

U2 - 10.1074/mcp.M113.036095

DO - 10.1074/mcp.M113.036095

M3 - Article

VL - 13

SP - 907

EP - 917

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 3

ER -